Home › FDA Approves The Patheon Site In Bourgoin, France To Manufacture Drugs For U.S. Market
 

Keywords :   


FDA Approves The Patheon Site In Bourgoin, France To Manufacture Drugs For U.S. Market

2014-05-09 16:12:50| drugdiscoveryonline News Articles

Patheon , the pharmaceutical services business owned by DPx Holdings, recently received FDA approval for its Bourgoin, France site to begin manufacturing and selling drugs to the U.S. market. The Bourgoin site specializes in development and commercial scale manufacture of solid oral forms and non-sterile liquids.

Tags: site us france market

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.06Atlantic Tropical Weather Outlook
23.06Eastern North Pacific Tropical Weather Outlook
23.06Atlantic Tropical Weather Outlook
23.06What are my rights if my flight is cancelled or delayed?
23.06Atlantic Tropical Weather Outlook
23.06Eastern North Pacific Tropical Weather Outlook
23.06British Gas sorry for pursuing man over wrong 2,500 bill
23.06Airport 'stay away' warning amid major power cut
More »